Genetic Predisposition to Stevens–Johnson Syndrome With Severe Ocular Surface Complications

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cornea

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/ICO.0000000000000605PMID 26448174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.

  2015cited by this paper
• HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications

  2015cited by this paper
• Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

  2015cited by this paper
• Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement

  2014cited by this paper
• Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications

  2014cited by this paper
• Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes.

  2012cited by this paper
• HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications

  2012cited by this paper
• Ocular surface inflammation is regulated by innate immunity.

  2012cited by this paper
• Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders

  2011cited by this paper
• HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

  2011cited by this paper
• Prostaglandin E Receptor Subtype Ep4 Expression In Human Conjunctival Epithelium And Its Changes In Various Ocular Surface Disorders

  2011cited by this paper
• A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

  2011cited by this paper
• Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study.

  2010cited by this paper
• Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.

  2009cited by this paper
• Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.

  2009cited by this paper
• A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

  2008cited by this paper
• HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.

  2008cited by this paper
• Association of Fas Ligand gene polymorphism with Stevens–Johnson syndrome

  2008cited by this paper
• Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.

  2008cited by this paper
• Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens–Johnson syndrome

  2007cited by this paper
• Association of IL4R polymorphisms with Stevens-Johnson syndrome.

  2007cited by this paper
• Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.

  2007cited by this paper
• Prostaglandin Receptor Signaling in Disease

  2007cited by this paper
• Erythema multiforme

  2007cited by this paper
• HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

  2005cited by this paper
• Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

  2005cited by this paper
• A marker for Stevens–Johnson syndrome

  2004cited by this paper
• Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.

  1995cited by this paper
• The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.

  1990cited by this paper
• Etiologic Factors of the Stevens‐Johnson Syndrome

  1980cited by this paper
• Genome-wide association study identifies HLA-A ∗ 3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

  year unknowncited by this paper

• Drug‐Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper

  2025cites this paper
• Identifying New Candidate Predictors of Mortality in Japanese Patients with Severe Drug Eruptions

  2025cites this paper
• Ocular Manifestations and Outcomes in Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison with Adult Patients.

  2023cites this paper
• Genetic predisposition to ocular surface disorders and opportunities for gene-based therapies.

  2023cites this paper
• Chronic ocular sequelae in Stevens–Johnson syndrome: a genetic association study

  2022cites this paper
• Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention

  2021cites this paper
• Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese

  2021cites this paper
• Stevens Johnson syndrome: A review of a vision and life-threatening mucocutaneous disease including histopathology with updates on pathogenesis and genetic risk factors

  2021cites this paper
• Clinical Characteristics of Patients With Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom

  2021cites this paper
• Adult-onset Atypical Stevens-Johnson Syndrome with HLA-A*11:01 and HLA-A*31:01 Alleles

  2021cites this paper
• Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome.

  2021cites this paper
• Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications

  2021cites this paper
• Skin and Lacrimal Drainage System

  2020cites this paper
• Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications

  2020cites this paper
• Therapeutic Effects of Mesenchymal Stem Cells on a Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Model

  2020cites this paper
• HLA genotypes and cold medicine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis

  2020cites this paper
• Conjunctivitis Preferred Practice Pattern®.

  2019cites this paper
• Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond

  2019cites this paper
• Ocular Disease in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

  2019cites this paper
• Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand

  2018cites this paper
• A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision

  2018cites this paper
• Factors Contributing to Long-Term Severe Visual Impairment in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

  2017cites this paper
• Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population

  2017cites this paper
• Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions

  2016cites this paper